Skip to main content
. 2019 Feb 11;49(1):20–26. doi: 10.3906/sag-1806-1

Table 1.

Comparison of RA, SLE, and control groups.

RA (n = 47) SLE (n = 32) Control (n = 47) P
Age, mean ± SD 52.1 ± 11.9 41.4 ± 14.5 47.2 ± 17.3 0.01
Female, n (%) 39 (83.0) 27 (84.4) 36 (80.0) 0.87
Diabetes, n (%) 4 (8.5) 1 (3.1) 5 (11.1) 0.44
Hypertension, n (%) 19 (40.4) 10 (31.3) 12 (26.7) 0.36
Dyslipidemia, n (%) 9 (19.1) 1 (3.1) 6 (13.3) 0.11
Smoking, n (%) 14 (29.8) 12 (37.5) 13 (28.9) 0.69
BMI, mean ± SD 27.9 ± 5.0a 25.8 ± 4.9b 26.2 ± 4.6 0.13
CRP, mg/dLc 0.6 (0.1–4.2) 0.4 (0.1–20.6) n/a 0.05*

BMI: Body mass index; CRP: C-reactive protein; n/a: not available; RA: rheumatoid arthritis; SLE: systemic lupus erythematosus; a: 1, b: 2 missing data; c: median and min–max. *: CRP value is only available for RA and SLE patients. Bold font indicates statistically significant difference.